Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
  • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
  • A61K8/20—Halogens; Compounds thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
  • A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
  • A61K8/24—Phosphorous; Compounds thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
  • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/60—Sugars; Derivatives thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/67—Vitamins
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
  • A61F13/00—Bandages or dressings; Absorbent pads
  • A61F2013/00361—Plasters
  • A61F2013/00727—Plasters means for wound humidity control
  • A61F2013/00748—Plasters means for wound humidity control with hydrocolloids or superabsorbers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
  • A61Q1/02—Preparations containing skin colorants, e.g. pigments

Definitions

• Tissue culture media as an ingredient in cosmetics
• the invention encompasses cosmetic or dermatological preparations containing tissue, in particular skin cell culture media, in particular aqueous serum-free media, and the use of the preparations for skin, hair and body care.
• cells are removed from this network, they have to be cultivated in "environments" that come as close as possible to the natural living conditions in the body. In doing so, the transport and transport of nutrients and the presence of vital factors must be ensured.
• cell culture media The mostly liquid medium enables the multiplication of microorganisms or cells. Basically, the composition of the cell culture medium depends on the needs of the cells to be grown. A distinction is made between synthetic media, the ingredients of which are precisely known on the basis of pure substances, and complex media, the exact composition of which can fluctuate and is sometimes not exactly known.
• cell culture media mostly contain a carbon and a nitrogen source, phosphate and sulfur compounds as well as minerals and possibly growth substances or vitamins.
• the cells can multiply or produce the factors necessary for survival "in situ" themselves.
• the "steady state” conditions in the tissue can be simulated by suitable intervals in the change of media.
• Sera are often added to the cell culture media to generate good cell growth. Sera are natural products and are obtained from the blood sera of calf, beef, pork, goat, horse or from human blood serum. These sera are complex mixtures of different biomolecules, the functionalities of which are tailored to the respective species. They contain, for example, hormones, attachment factors, amino acids, etc. Depending on the origin of the serum sources, the individual containing factors are variable and the batches of even inter-individual sera are sometimes significantly different. Biological experiments cannot be reproduced at times because the composition of the sera used cannot be reproduced by subsequent batches.
• serum-free culture media enable the cultivation of cells under controlled and defined conditions, so that undesired effects due to fluctuations in the serum composition are eliminated.
• use of serum-free media reduces the contamination of cell cultures with viruses and bacteria.
• the cornified epidermis forms the protective shield of the skin.
• the skin cells keratinocytes
• epidermal differentiation After the cells in the basal layer have divided, the keratinocytes migrate to the surface of the skin and undergo a series of changes until they become dead, flat, nucleated coromeocytes in the horny layer (stratum corneum) and finally desquamate.
• Various proteins with specific functions are formed during epidermal differentiation. These include keratins, involucrin, filaggrin and transglutaminase. For optimal formation of the epidermis and the horny layer, it is necessary that these proteins are coordinated and produced in sufficient quantities.
• the aging skin is primarily treated cosmetically with vitamin A derivatives or hydroxy acids, which stimulate the proliferation of the basal cells in the epidermis to thicken the epidermis and thus smooth the skin.
• vitamin A derivatives or hydroxy acids which stimulate the proliferation of the basal cells in the epidermis to thicken the epidermis and thus smooth the skin.
• More recent approaches are to substitute for the proteins that are missing or diminished in the dry or the aging skin or to intervene indirectly in the metabolic processes that are disturbed in the case of dry skin or with increasing age. to normalize.
• One example is the stimulation of collagen synthesis with the purpose of reducing wrinkles.
• laminin substances to extend the lifespan of skin cells and certain extracts are used to stimulate epidermal differentiation.
• some of these are pharmacologically active substances with a high potential for side effects.
• the aim of the invention is to improve the supply of the skin with essential, mineral or • organic biofactors.
• the object of the present invention is therefore to provide a cosmetic or dermatological preparation which makes it possible for the skin to regenerate itself without the harmful side effects or undesirable side effects occurring.
• Another object of the present invention is to provide preparations which enrich the prior art and can be used for skin, hair and body care and for the treatment of skin irritation and burns.
• the listed tasks are solved by a cosmetic or dermatological preparation according to the main claim.
• the subclaims relate to advantageous embodiments of the preparations according to the invention.
• the invention comprises the use of such preparations for the treatment of skin diseases and for skin, hair or scalp care.
• cosmetic and / or dermatological preparations containing one or more tissues accomplish the tasks set.
• skin cell culture media which are suitable for the cultivation of organotypic skin cultures and for the cultivation of fibroblasts and keratinocytes can be regarded as advantageous for use in cosmetic and / or dermatological preparations.
• the preparations in which the media is selected from Ham's F10, Ham's F12 or MCDB, alone or in mixtures, in particular DMEM / HAM 's F-12 (1: 1) and / or MCDB 153 are particularly advantageous.
• Serum-free preparation in particular avoids the disadvantages listed in the prior art.
• tissue culture medium is understood by the person skilled in the art to mean all liquid, semi-solid or solid media or mixtures of mineral components, vitamins, enzymes, proteins, proteids or trace elements in or on which the tissue, in particular skin cells, can be replicated or can be cultivated.
• the tissue culture media according to the invention are thus particularly suitable for the cultivation of skin cells of all kinds, but also also for the cultivation of cells of non-dermal origin in the skin, such as melanocytes, Langerhans cells, Merkel cells etc. Skin cells are preferably considered tissue according to the invention.
• the skin cell culture media according to the invention accordingly comprise those media whose composition of their individual components is suitable for the cultivation of the following tissues:
• Fibroblast cells Fibroblast cells, keratinocyte cells, co-cultures from keratinocytes and fibroblasts, co-cultures from fibroblasts / keratinocytes and other skin-relevant cells such as immune cells, melanocytes etc.
• the use of the culture media relevant to the skin requires the autologous, healthy and individual regeneration of deficient skin functions in vivo.
• the regeneration of the skin, the firmness of the skin or simply the contribution to skin care can be significantly improved.
• tissue and in particular skin cell culture media are suitable for use in cosmetic preparations.
• those skin cell culture media are suitable which are used in the literature for the cultivation of skin or skin-relevant cells, for the treatment of skin irritation and burns.
• Media for the cultivation of remaining cells after massive burns in particular show an extremely advantageous effect after application of the topical preparations, namely a quick, pain-free restoration of the initial state of the healthy skin.
• Advantageous skin cell culture media according to the invention are also media which allow the maintenance and neogenesis of fibroblasts or keratinocytes alone or in mixed cultures.
• the ratios of the contents of the cell culture media to mineral or organic biofactors are selected so that they are suitable for the maintenance, cultivation and care of skin cells in vitro, ex vivo and in vivo.
• So-called serum-free media have proven to be particularly advantageous if the cell fraction of the keratinocytes is to be positively influenced in the sense of an optimized homeostasis.
• the cosmetic or dermatological preparations according to the invention which contain skin cell culture media for the cultivation of skin cells, are able to activate, in or on the human skin itself, those mechanisms which the skin uses for homeostasis and autopoiesis.
• Mixtures of fibroblasts or keratinocyte-relevant growth media can be used directly or in suitable vesicle technologies and can be used for medical / pharmaceutical purposes and cosmetic purposes.
• Suitable vesicle systems are preferably membrane systems, e.g. Liposomes or cyclodextrin preparations as well as micro - or nanoemulsions based on fluid or solid lipids.
• the advantage of these vesicular applications is the transfer of media to or through the skin barrier at their epidermal or dermal site of action.
• This combination of skin cell culture media and vesicle technology, especially cosmetic emulsion preparations, makes it possible to guarantee efficient treatment and care of the skin in the first place.
• This synergistic combination of the provision of specific, in particular serum-free, skin cell culture media, incorporating them into suitable topical preparations and application of these preparations to the skin creates optimal conditions, which enable the skin to regenerate itself and maintain a healthy flow balance, homeostasis, and to stimulate autopoiesis.
• Autopoiese according to the definition by Maturana / Varela, means strict autonomy for living systems on the one hand, on the other hand, this concept emphasizes the intensity and degree of integration between living systems and their environment.
• Autopoietic systems are structurally determined, ie they are structurally coupled with the medium and other living systems in interactions.
• this autopoiesis means permanent, healthy renewal of itself if the environmental conditions and nutrient offers are adequate. Exactly these conditions and offers are provided by the preparations according to the invention.
• Tissue culture media which contain the following constituents in the stated concentration ranges are particularly preferred according to the invention:
• a cosmetic preparation comprising a tissue culture medium, containing the components listed in the table, fulfills the task and is excellently suitable for the treatment of skin diseases and for skin, hair and scalp care.
• the skin cell culture media DMEM / HAM s s F-12 (1: 1) and MCDB 153 are particularly suitable for use in cosmetic preparations according to the invention. However, individual adaptations of these preparations are advantageous here. These adjustments can be made in the change of
• Serum substitute compositions or in varying ratios of the concentrations of the media components are also possible which are produced by neglecting choline chloride, corresponding selenium salts etc.
• DMEM Dulbesccos Modified Eagles medium
• This medium is the basis for the cultivation of cell lines for human proteins, such as erythropoietin.
• DMEM / HAM 's F-12 (1: 1) is composed of (given in mg / l):
• MCDB 153 becomes Barnes D. and Sato G .; Anal. Biochem 102, 255 [1980] used for the cultivation of human keratinocytes. Also as minimal medium PBS, phosphate-buffered saline, with pH values from 3.5 to 8.
• MCDB 153 is composed of (mg / l):
• the advantage of the DMEM / HAM ' s F-12 (1: 1) and MCDB 153 media is that in cosmetic or dermatological preparations they are specially selected and suitable for the cultivation of monolayers, two-dimensional and organotypical skin models, and they are in vitro and Allow ex vivo stimulation or preservation of skin-specific bio functions.
• tissue in particular skin cell culture media can simply be used as a component of the water phase in the cosmetic or dermatological preparations, and they can also completely replace the water phase of the preparation.
• the proportion of tissue culture media is therefore 0.1 to 100% by weight, preferably 1 to
• this is an aqueous preparation consisting of 100% by weight
• Skin cell culture medium e.g. Use MCDB 153 as indicated above as a cosmetic preparation.
• serum substitutes can be used by osmotic regulators from the groups of proteoglycans, glycoproteins, collagens, chitin derivatives (chitosan) or mixtures thereof, such as, for example, chitosan / chondroitin-6-sulfate / collagen or plant skin function inducers which stimulate are able to optimize essential factors in cell cultures.
• Trace elements such as serum substitute A from Seromed and / or the addition of extracellular matrix substances such as collagen, chondroitin-6-sulfate and chitosan are also suitable as serum substitutes.
• SES serum substitutes
• a particularly advantageous combination is the combination of cell-nourishing culture media, preferably media for the cultivation of skin or coma cultures of all kinds with a cellular matrix comprising collagen, chitosan with a degree of acetylation of up to 50% and glycosylaminoglycan.
• the glycosylaminoglycan is selected from chondroitin 4 and / or chondroitin 6 sulfate.
• a preparation containing collagen, acetylated chitosan with a degree of acetylation of up to 50%, preferably up to 40%, and chondroitin sulfates is therefore particularly preferred.
• the collagen is preferably obtained from maritime collagens selected from the group of type 3, type 1, type 4 and / or type 5 or mixtures thereof.
• the invention enables the regeneration of skin or partial skin from individual cells (dermis and epidermis), as well as the transfer of this in vitro pre-cultivated gel matrix to damaged tissue for complete skin renewal or the prevention or reduction of scar tissue during wound healing.
• the present invention also provides the ideal environment (matrix) for renewing the skin when applied topically.
• EP 296078 The preparation of the matrix is described in EP 296078.
• the disclosure content of EP 296078 is hereby fully included in the present invention.
• the matrix described in EP 296078 can also be obtained in its entirety by maritime and or synthetic raw material sources and leads to the same results as in patent EP 296078 Solutions of the following composition A or B can also advantageously be added to the media as serum substitutes, the concentrations of the solutions depending on the application varying from 0.1 to 10,000 ⁇ g.
• the serum substitutes are preferably used as osmo regulators.
• liquid media mostly pure, pyrogen-free water is used for the production of the liquid media, this corresponds to the WFI quality (water for injection) according to Pharmacopoeia Europe.
• the liquid media are sterile filtered and filled, whereby the systems and manufacturing instructions are designed so that the entry of endotoxins and germs is largely excluded.
• pure spring water can also be used.
• the media according to the invention have advantageous properties with regard to skin regeneration.
• Glutamine and / or stabilized glutamine, stabilized glutamine N-acteyl-alanyl glutamine can optionally be added to the media.
• tissue, in particular skin cell culture media and any additives are mixed in cosmetic or dermatological preparations in a proportion of up to 99.9% by weight, based on the total mass of the preparation.
• the culture conditions can thus be individually adapted to the respective purpose by using the components and their proportions modified compared to the standard media.
• Cosmetic or dermatological preparations are to be understood as topical preparations which are suitable for applying the media mentioned to the skin in a fine distribution and preferably in a form which can be absorbed by the skin.
• aqueous and aqueous-alcoholic solutions sprays, foams, foam aerosols, ointments, aqueous gels, emulsions of O / W, W / O or W / O ⁇ / V type, microemulsions or cosmetic stick preparations.
• a particularly preferred carrier is an aqueous gel, an O / W emulsion or a microemulsion.
• the preparation also in personal cleansers such. B. soaps, shower rooms, shampoos and. ⁇ . are used.
• the cosmetic formulations are O / W emulsions.
• lipids known in cosmetics can be used as the oil or lipid phase.
• lipids is used as a generic term for fats, oils, waxes and the like, as is well known to the person skilled in the art.
• oil phase and “lipid phase” are also used synonymously.
• Suitable polar oils are, for example, those from the group of lecithins and fatty acid triglycerides, in particular the triglycerol esters of saturated and / or unsaturated saturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12 to 18, carbon atoms.
• the fatty acid triglycerides can, for example, advantageously be selected from the group of synthetic, semisynthetic and natural oils, such as, for example, olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grape seed oil, safflower oil, evening primrose oil, macadamia nut oil and the like more.
• synthetic, semisynthetic and natural oils such as, for example, olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grape seed oil, safflower oil, evening primrose oil, macadamia nut oil and the like more.
• Particularly advantageous polar lipids for the purposes of the present invention are all native lipids, such as, for. As olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grape seed oil, safflower oil, evening primrose oil, macadamia nut oil, corn oil, avocado oil and the like and those listed below.
• the oil phase can advantageously be selected from the group of dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols. It is particularly advantageous if the oil phase has a content of C 12 - having 1 Alkylbe ⁇ zoat 5- or consists entirely of this.
• the oil phase can advantageously be selected from the group of Guerbet alcohols.
• Guerbet alcohols are named after Marcel Guerbet, who described their production for the first time. They arise according to the reaction equation
• Guerbet alcohols are liquid even at low temperatures and practically cause no skin irritation. They can advantageously be used as greasing, over-greasing and also moisturizing components in skin and hair care products.
• Ri and R 2 generally mean unbranched alkyl radicals.
• the Guerbet alcohol or alcohols are advantageously selected from the
• Ri propyl, butyl, pentyl, hexyl, heptyl or octyl and
• R 2 hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl or tetradecyl.
• Guerbet alcohols preferred according to the invention are 2-butyloctanol - it has the chemical structure
• C10H21 and is available, for example, under the trade name Isofol® 16 from Condea Chemie GmbH.
• Mixtures of Guerbet alcohols according to the invention can also be used advantageously according to the invention.
• Mixtures of 2-butyloctanol and 2-hexyldecanol are available, for example, under the trade name Isofol® 14 from Condea Chemie GmbH.
• the total amount of Guerbet alcohols in the finished cosmetic or dermatological preparations is advantageously selected from the range up to 25.0% by weight, preferably 0.5-15.0% by weight, based on the total weight of the preparations.
• waxes for example cetyl palmitate, as the sole lipid component of the oil phase.
• medium-polar lipis in the sense of the present invention are the substances listed below:
• Nonpolar oils are, for example, those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular petroleum jelly (petrolatum), paraffin oil, squalane and squalene, polyolefins and hydrogenated polyisobutenes.
• petroleum jelly petroleum jelly
• paraffin oil squalane and squalene
• polyolefins polyolefins
• hydrogenated polyisobutenes are the preferred substances.
• the oil phase can advantageously be selected from the group of branched and unbranched hydrocarbons and waxes, the dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and also the fatty acid triglycerides, especially the triglycerol esters saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12-18, carbon atoms.
• the fatty acid triglycerides can, for example, advantageously be selected from the group of synthetic, semisynthetic and natural oils, e.g. Olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil and the like, provided the conditions specified in the main claim are met.
• Fat and / or wax components to be used advantageously according to the invention can be selected from the group of vegetable waxes, animal waxes, mineral waxes and petrochemical waxes.
• Favorable according to the invention are, for example, candelilla wax, camauba wax, Japanese wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax, sugar cane wax, berry wax, ouricury wax, montan wax, jojoba wax, shea butter, beeswax, shellac wax, walrus, lanolin (wool wax), Bürzelfett, cerinin Earth wax), paraffin waxes and micro waxes, provided the conditions specified in the main claim are met.
• fat and / or wax components are chemically modified waxes and synthetic waxes, such as those under the trade names Syncrowax HRC (glyceryl tribehenate), and Syncrowax AW 1C (C 8-3 6 - fatty acid) available from CRODA GmbH as well as montan ester waxes, sasol waxes, hydrogenated jojoba waxes, synthetic or modified beeswaxes (e.g. dimethicone copolyol beeswax and / or C 30 - 5 o-alkyl beeswax), polyalkylene waxes, polyethylene glycol waxes, but also chemically modified fats, such as. B.
• Syncrowax HRC glycol tribehenate
• Syncrowax AW 1C C 8-3 6 - fatty acid
• hydrogenated vegetable oils for example hydrogenated castor oil and / or hydrogenated coconut fat glycerides
• triglycerides such as trihydroxystearin, fatty acids, fatty acid esters and glycol esters.
• organosilicon compounds which have similar physical properties to the fat and / or wax components mentioned, such as stearoxytrimethyisilane, provided the conditions specified in the main claim are met.
• the fat and / or wax components can be present either individually or in a mixture. Any mixtures of such oil and wax components can also be used advantageously for the purposes of the present invention.
• the oil phase selected from the group 2-ethylhexyl, octyldodecanol, isotridecyl, butylene glycol dicaprylate / dicaprate, 2-ethylhexyl cocoate, C 2- i like -Alky benzoate!, Caprylic-capric acid triglyceride, dicaprylyl ether provided the conditions required in the main claim Conditions are met.
• Mixtures of octyldodecanol, caprylic-capric acid triglyceride, dicaprylyl ether, dicaprylyl carbonate, cocoglycerides, or mixtures of C 12 -is alkylbenzoate and 2-ethylhexyl isostearate, mixtures of C 12- 5 -alkybenzoicaprate and butylate glycolate / butylate glycolate are particularly advantageous
• paraffin oil cycloparaffin, squalane, squalene, hydrogenated polyisobutene or polydecene
• silicone oils can be present as monomers, which are usually characterized by structural elements, as follows:
• Silicone oils are high-molecular synthetic polymeric compounds in which silicon atoms are linked in a chain and / or network-like manner via oxygen atoms and the remaining valences of silicon by hydrocarbon residues (mostly methyl, more rarely ethyl, propyl, phenyi groups, etc.) are saturated.
• silicon atoms can be substituted with the same or different alkyl radicals and / or aryl radicals, which are generally represented here by the radicals R 1 - R 4 (to say that the number of different radicals is not necessarily limited to up to 4), m can assume values from 2 - 200,000.
• linear silicone oils are systematically referred to as polyorganosiloxanes; the methyl-substituted polyorganosiloxanes, which are the most important compounds of this group in terms of quantity and are distinguished by the following structural formula
• Dimethicone is also known as polydimethylsiloxane or dimethicone (INCI). Dimethicone is available in different chain lengths or with different molecular weights. Dimethicones of different chain lengths and phenyltrimethicones are particularly advantageous linear silicone oils for the purposes of the present invention.
• Particularly advantageous polyorganosiloxanes for the purposes of the present invention are, for example, dimethylpolysiloxanes [polydimethylsiloxane)], which, for. B. are available under the trade names ABIL 10 to 10,000 from Th. Goldschmidt.
• phenylmethylpolysiloxanes INCI: phenyl dimethicone, phenyl trimethicone
• cyclic silicones octamethylcyclotetrasiloxane or decamethylcyclopentasiaioxane
• polysiloxane-polyalkylene copolymers (INCI: stearyl dimethicone and cetyl dimethicone) and dialkoxydimethyl polysiloxanes (stearoxy dimethicone and behenoxy stearyl dimethicone), which are available as • different abil wax types from Th. Goldschmidt.
• n can take values from 3/2 to 20. Broken values for n take into account that there may be odd numbers of siloxyl groups in the cycle. , , '
• Particularly advantageous cyclic silicone oils for the purposes of the present invention are cyclomethicones, in particular cyclomethicones D5 and / or cyclomethicones D6.
• silicone oils or silicone waxes in the sense of the present invention are cyclic and / or linear silicone oils and silicone waxes.
• the ratio of lipids to silicone oils approximately as 1: 1 (generally x: y).
• Phenyltrimethicone is advantageously chosen as the silicone oil.
• Other silicone oils for example dimethicone, phenyldimethicone, cyclomethicone (octamethylcyclotetrasiloxane), for example hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane), cetyldimethicone, behenoxydimethicone, can also be used advantageously for the purposes of the present invention.
• Mixtures of cyclomethicone and isotridecyl isononanoate and those of cyclomethicone and 2-ethylhexyl isostearate are also advantageous.
• silicone oils of a similar constitution to the compounds described above, the organic side chains of which are derivatized, for example polyethoxylated and / or polypropoxylated.
• these include, for example, poly-siloxane-polyalkyl-polyether copolymers such as the cetyl-dimethicone copolyol and the cetyl-dimethicone copolyol (and) polyglyceryl-4-isostearate (and) hexyl laurate.
• Preparations according to the invention in the form of emulsions contain one or more emulsifiers.
• emulsifiers can advantageously be selected from the group of nonionic, anionic, cationic or amphoteric emulsifiers.
• nonionic emulsifiers are a) partial and fatty acid ester of polyhydric alcohols and their ethoxylated derivatives (eg. B. Giycerylmonostearate, sorbitan stearates, Glycerylstearylcitrate, Sucrosestearate) b) ethoxylated fatty alcohols and fatty acids c) ethoxylated fatty amines, fatty acid amides, fatty acid alkanolamides d) alkylphenol polyglycol ethers (such as Triton X)
• the anionic emulsifiers include a) soaps (e.g. sodium stearate) b) fatty alcohol sulfates c) mono-, di- and trialkylphosphonic acid esters and their ethoxylates
• the cationic emulsifiers include a) quaternary ammonium compounds with a long-chain aliphatic radical, e.g. Distearyldimonium Chloride
• amphoteric emulsifiers include a) alkylamininoalkane carboxylic acids b) betaines, sulfobetaines c) imidazoline derivatives There are also naturally occurring emulsifiers, which include beeswax, wool wax, lecithin and sterols.
• O / W emulsifiers can, for example, advantageously be chosen from the group of polyethoxylated or polypropoxylated or polyethoxylated and polypropoxylated products, for example: the fatty alcohol ethoxylates of the ethoxylated wool wax alcohols, the polyethylene glycol ether of the general formula RO ⁇ (-CH 2 -CH 2 -O -) n -R ', the fatty acid ethoxylates of the general formula
• RO - (- CH 2 -CH 2 -O-) n -CH 2 -COOH and n represent a number from 5 to 30, the polyoxyethylene sorbitol fatty acid esters, the alkyl ether sulfates of the general formula RO - (- CH 2 -CH 2 -O-) ⁇ -SO 3 -H - the fatty alcohol propoxylates of the general formula
• the polyethoxylated or polypropoxylated or polyethoxylated and polypropoxylated O / W emulsifiers used are selected from the group of substances with HLB values of 11-18, very particularly advantageously with HLB values of 14.5 - 15.5 if the O / W emulsifiers have saturated radicals R and R '. If the O / W emulsifiers have unsaturated radicals R and / or FI ', or if isoalkyl derivatives are present, the preferred HLB value of such emulsifiers can also be lower or higher.
• fatty alcohol ethoxylates from the group of ethoxylated stearyl alcohols, cetyl alcohols, cetylstearyl alcohols (cetearyl alcohols).
• Particularly preferred are: polyethylene glycol (13) stearyl ether (Steareth-13), polyethylene glycol (14) stearyl ether (Steareth-4), polyethylene glycol (15) stearyl ether (Steareth-15), polyethylene glycol (16) - stearyl ether (Steareth-16), polyethylene glycol (17) stearyl ether (Steareth-17), polyethylene glycol (18) stearyl ether (Steareth-18), polyethylene glycol (19) stearyl ether (Steareth-19), polyethylene glycol (.20) stearyl ether (Steareth-20), Polyethylene glycol (12) isostearyl ether (isosteareth-12), polyethylene glycol (13) isostearyl ether (isosteareth-13), polyethylene glycol (14)
• Polyethylene glycol (12) lauryl ether (Laureth-12), polyethylene glycol (12) isolauryl ether (Isoureth-12).
• fatty acid ethoxylates from the following group: Polyethylene glycol (20) stearate, Polyethy! Englycol (21) stearate, Polyethy! Englycol (22) stearate, Polyethylene glycol (23) stearate, Polyethylene g! Ycol (24) stearate, Polyethylene glycol (25) - stearate,
• the sodium laureth-11 carboxylate can advantageously be used as the ethoxylated alkyl ether carboxylic acid or salt thereof become.
• Sodium laureth 1-4 sulfate can advantageously be used as the alkyl ether sulfate.
• polyethylene glycol (30) cholesteryl ether can advantageously be used.
• Polyethylene glycol (25) soyasterol has also proven itself.
• polyethylene glycol glycerol fatty acid esters from the group polyethylene glycol (20) glyceryl laurate, polyethylene glycol (21) glyceryl laurate, polyethylene glycol (22) glyceryl laurate, polyethylene! Eng! Ycol (23) glycery! Laurate, polyethylene glycol (6) glyceryl caprate / caprinate, polyethylene glycol (20) glyceryl oleate, polyethylene glycol (20) glyceryl isearate, polyethylene glycol (18) glyceryl oleate / cocoate.
• sorbitan esters from the group consisting of polyethylene glycol (20) sorbitan monolaurate, polyethylene glycol (20) sorbitan monostearate, polyethylene glycol (20) to choose bitanmonoisostearate, polyethylene glycol (20) sorbitan monopalmitate, polyethylene glycol (20) sorbitan monooleate.
• W / O emulsifiers fatty alcohols with 8 to 30 carbon atoms, monoglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12 to 18 carbon atoms, diglycerol esters saturated and / or unsaturated, branched and / or unbranched alkane carboxylic acids with a chain length of 8 to 24, in particular 12 - 18 C atoms, monoglycerol ethers saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 8 to 24, in particular 12 - 18 C - Atoms, diglycerol ethers of saturated and / or unsaturated, branched and / or unbranched alcohols with a chain length of 8 to 24, in particular 12-18 C atoms, propylene glycol esters of saturated and / or unsaturated, branched and / or unbranched alcohols
• W / O emulsifiers are glyceryl monostearate, glyceryl isostearate, glyceryl monomyristate, glyceryl, diglyceryl monostearate, diglycerol rylmonoisostearat, lenglycolmonocaprylat propylene glycol, propylene glycol monoisostearate, propylene, Propylenglycoim ⁇ nolaurat, sorbitan, sorbitan monolaurate, sorbitan, Sorbitanmonoisooleat, sucrose, cetyl alcohol, Stearyl alcohol, arachidyl alcohol, behenyl alcohol, isobehenyl alcohol, selachyl alcohol, chirnyl alcohol, polyethylene glycol (2) stearyl ether (steareth-2), glyceryl mono laurate, glyceryl monocaprinate, glyceryl monocaprylate.
• the emulsifier systems mentioned can be added to the preparations.
• Steareth-2, Steareth 21 and PEG-20-100 stearate are advantageous emulsifier systems.
• the preparations contain, in addition to the substances mentioned above, the additives which are customary in cosmetics, for example perfume, dyes, antimicrobial substances, lipid-replenishing agents, complexing and sequestering agents, pearlescent agents, plant extracts, vitamins, active ingredients, preservatives, bactericides, pigments , which have a coloring effect, thickeners, softening, moisturizing and / or moisturizing substances, or other common components of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.
• the additives which are customary in cosmetics, for example perfume, dyes, antimicrobial substances, lipid-replenishing agents, complexing and sequestering agents, pearlescent agents, plant extracts, vitamins, active ingredients, preservatives, bactericides, pigments , which have a coloring effect, thickeners, softening, moisturizing and / or moisturizing substances, or other common components of a
• Suitable preparations are also those that can be used for professional wound care or wound healing, such as polyurethane preparations or wound dressings, chitosan / cola agents / chondroitin-6-suifat sponges or solutions.
• the skin oil culture media can, for example, also be incorporated into polymer matrices, such as in particular polyurethane matrices, and used as wound dressings.
• the incorporation can be carried out directly or advantageously encapsulated. Suitable encapsulation materials are known to the person skilled in the art and are known from the prior art.
• the added antioxidants are advantageously selected from the group consisting of amino acids (eg glycine, lysine, arginine, cysteine, histidine, tyrosine, tryptophan) and their derivatives (as salt, ester, ether, sugar, nucleotide, nucleoside) , Peptide and lipid linkage), imidazoie (eg urocanic acid) and their derivatives (as salt, ester, ether, sugar, nucleotide, nucleoside, peptide and / or lipid linkage), peptides such as D , L-camosine, D-carnosine, L-gamosine, anserine and their derivatives (eg as salt, ester, ether, sugar, thioi, nucleotide, nucleoside, peptide and lipid compound), carotenoids , Caroline (e.g.
• ⁇ -carotene ß-ca'otin, ⁇ -lycopene r phytoene,
• their derivatives e.g. as salt, ester, ether, sugar, nucleotide, nucleoside, peptide
• Chlorogenic acid and derivatives thereof as salt..
• metal chelators eg apoferritin, desferral, lactoferrin, ⁇ -hydroxy fatty acids, palmitic acid, phytic acid
• their derivatives as salt, ester, ether, sugar, thiol, nucleotide, nucleoside, Peptide and / or lipid compound
• ⁇ -hydroxy acids e.g.
• citric acid lactic acid, malic acid
• humic acid bile acid
• bile extracts bilirubin
• biiverdin bilirubin
• EDTA EDTA
• EGTA unsaturated fatty acids and their derivatives
• glycosylrutin, ferulic acid, caffeic acid furfurylidene glucitol, butylated hydroxytoluene, butylated hydroxyanisole, nordihydroguajak resin acid, nordihydroguajaretic acid, trihydroxybutyrophenone and their derivatives (as salt, ester, nucleotide, sugar, sugar) , Peptide and lipid linkage).
• Uric acid and its derivatives, mannose and its derivatives (as salt, ester, ether, sugar, thiol, nucleotide, nucleoside, peptide and lipid compound).
• Zinc and its derivatives e.g.
• ZnO, ZnSO 4 selenium and its derivatives (e.g. selenium methionine, Ebselen), stilbenes and their derivatives (e.g. stilbene oxide, trans-stilbene oxide) and the derivatives suitable according to the invention (as salt, ester, ether , Sugar, thiol, nucleotide, nucleoside, peptide and / or lipid compound) of these active ingredients mentioned.
• the preparations according to the invention are prepared, for example as an emulsion, by known production processes. First, an emulsion from the oil and formed in the water phase and then added the aqueous cell culture media phase.
• the incorporation of the cell culture media into the cosmetic formulations should follow at a maximum of 48 ° C, preferably at less than 35 ° C, ideally at 30 ° C due to the thermolability of the medium.
• the medium is added slowly and the temperature fluctuates by more than max. Avoid 4-5 ° C.
• the medium is advantageously stored and also used at refrigerator temperatures, thus avoiding excessive cooling during production, since it may crystallization and inhomogeneities can occur.
• Cartridge packaging or multiple emulsions can be guaranteed.
• Cell culture media are just as suitable for stabilizing W / O / W technologies as physiological saline solutions.
• Preservative exposure tests of the preparations according to the invention showed no susceptibility to contamination. Tests were carried out with the cosmetically customary use concentrations of preservatives 1 . Table 1 shows a list of the preservatives used.
• the formulations tested 1-1, 1-2, 2-1, 4-1 are O / W emulsions and a cleaning lotion (2-1).
• Preparation 1-1 and 2-1 contains the keratinocyte medium MCDB 153, preparation 1-2 and 4-1 DMEM / HAM's F-12.
• the emulsifier system is identical for samples 1-1 and 1-2.
• the packaging should be selected according to microbiological standards in order not to allow a possible recontamination by the customer.
• the cell medium cannot be incorporated immediately during the preparation of the preparation, it is possible to mix the cell culture medium and the cosmetic product only before use.
• this is achieved by special packaging elements, such as e.g. Double cartridges with mixing head, as they are known for example from 2-component glue, are guaranteed.
• the packaging of the cell culture medium could also be designed for refilling so that only fresh product is used. As mentioned, the use of powdered or solid skin cell culture media is also possible.
• the fat phase which contains the emulsifier, is heated to 80 ° C, the water phase as well, without the part that contains the medium. At 80 ° C both phases are combined, homogenized for about 3 - 10 minutes and then cooled to 48 ° C or room temperature. Then the water content is added to the medium and mixed with a constant temperature of ⁇ 1 ° C.
• the following preparations are prepared accordingly.
• Zinc sulfate 3.00% preservative. 0.50%
• PEG-80 behenate 2.00%
• Titanium dioxide 2.50 talc 5.00
• This example shows in an impressive manner the advantageous use according to the invention of a cosmetic preparation containing skin cell culture medium. Since the preparation can be used as make-up, it enables the user to cover it cosmetically, for example in the event of fire injuries, and likewise the user contributes to the regeneration and restoration of the injured skin without being externally visible. '

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Epidemiology (AREA)
• Birds (AREA)
• Chemical & Material Sciences (AREA)
• Inorganic Chemistry (AREA)
• Dermatology (AREA)
• Medicinal Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Cosmetics (AREA)
• Medicinal Preparation (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Applications Claiming Priority (4)

Publications (1)

Family

ID=33479380

Family Applications (3)

Family Applications After (2)

Country Status (4)

Families Citing this family (41)

Family Cites Families (72)

• 2004
  • 2004-05-22 EP EP04734472A patent/EP1635782A1/de not_active Ceased
  • 2004-05-22 WO PCT/EP2004/005532 patent/WO2004103333A1/de active Application Filing
  • 2004-05-22 JP JP2006529900A patent/JP2007500196A/ja active Pending
  • 2004-05-22 EP EP04078585.9A patent/EP2340856B2/de not_active Expired - Lifetime
  • 2004-05-22 EP EP04734469A patent/EP1896092A1/de active Pending
  • 2004-10-19 US US10/967,232 patent/US20050249691A1/en not_active Abandoned
• 2005
  • 2005-03-01 US US11/068,052 patent/US8518422B2/en active Active
  • 2005-11-23 US US11/285,342 patent/US8507276B2/en not_active Expired - Fee Related

Non-Patent Citations (2)

Also Published As

Similar Documents

Legal Events